Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dermatopathology Specimens Examined by Smartphone-Based Microscopy

By LabMedica International staff writers
Posted on 01 Feb 2016
The incorporation of high-resolution cameras into smartphones has allowed for a variety of medical applications including the use of lens attachments that provide telescopic, macroscopic, and dermatoscopic data. More...


Skin biopsy and the pathologic information that it provides is foundational to the diagnosis and management of dermatologic disease. However, a lack of expertise in dermatopathologic-specimen interpretation in resource-poor areas may impede timely diagnosis and treatment.

Pathologists at the University of Texas Houston Health Science Center (TX, USA) and their collaborators constructed a mobile phone microscope by using a modified method and a 3-mm-diameter sapphire ball lens purchased from Edmund Optics (Barrington, NJ, USA). A total of 1,130 consecutive dermatopathology specimens from mostly community dermatologists were evaluated. The performance characteristics of the smartphone platform were calculated by using conventional light microscopy as the gold standard. The sensitivity and specificity for the diagnosis of melanoma, non-melanoma skin cancers, and other miscellaneous conditions by the phone microscopy platform, as compared with traditional light microscopy, were calculated.

All excisional 101 specimens were excluded because the diagnosis was previously established. Among the 1,021 specimens, 930 (91.1%) were shave biopsies and 91 (8.9%) were punch biopsies from 763 different patients. For 136 basal cell carcinoma cases, the sensitivity and specificity of smartphone microscopy were 95.6% and 98.1%, respectively. The sensitivity and specificity for 94 squamous cell carcinoma cases were 89.4% and 97.3%, respectively. The lowest sensitivity was found in the 15 melanomas at 60%, although the specificity was high at 99.1%. The accuracy of diagnosis of inflammatory conditions and other neoplasms was variable.

The authors concluded that their study demonstrated the potential for a high-performing, low-cost smartphone microscopy system in the diagnosis of cutaneous disease. Studies with larger sample sizes of pigmented lesions, non-melanoma skin cancer (NMSC) subtypes, and dermatologic infections could help improve this modality for point-of-care diagnostics in resource-poor settings. The study was published in the January 2016 issue of the journal Archives of Pathology & Laboratory Medicine.

Related Links:

University of Texas Houston Health Science 
Edmund Optics



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.